Skip to main content
. 2022 Jun 15;11(12):3447. doi: 10.3390/jcm11123447

Figure 2.

Figure 2

Scatterplot showing the pre- and postoperative IOP of primary (circles) and secondary (crosses) MP-TSCPC treatments. The dotted line represents an IOP reduction of 20%.